Strong Antiplatelet Drugs May Worsen Brain Hemorrhage Recovery, Study Finds

A new study has explored how distinct antiplatelet medications impact recovery following a brain hemorrhage. These hemorrhages, known as intracranial bleeds, comprise approximately 10% of all strokes in the U.S., as per the American Heart Association's latest data. Researchers delved into whether stronger drugs might exacerbate outcomes compared to aspirin alone.

The research employed data from the American Heart Association's Get With The Guidelines-Stroke Registry. It centered on patients not on anticoagulants and tracked whether they passed away in hospital, entered hospice, or were discharged home. Earlier studies had lumped all antiplatelet therapies together, but this time, scientists sought to discern how individual drugs or combinations influenced survival and recovery.

Patients on potent antiplatelet medications—such as clopidogrel, prasugrel, or ticagrelor—either alone or with aspirin, faced an elevated risk of in-hospital death. They also exhibited a trend toward poorer overall outcomes. Conversely, those taking aspirin by itself showed no increased risk of dying and were more likely to leave hospital with a favorable result.

The findings do not imply that people should cease prescribed antiplatelet drugs. Instead, they emphasize how pre-existing medication choices may shape recovery after a brain hemorrhage. The study did not assess whether certain drugs raise the risk of bleeding initially. Current guidelines also advise against platelet transfusions for these patients unless surgery is urgent.

This work could pave the way for improved care strategies for hospitalized brain hemorrhage patients on antiplatelet therapy. Currently, standard practice involves halting these medications after a bleed, but further research may refine treatment approaches.

The study underscores the need for personalized care in brain hemorrhage patients using antiplatelet drugs. While aspirin alone showed better outcomes, stronger medications carried higher risks. These results may guide future updates to medical guidelines and enhance how doctors manage such cases.